Archive: Early Study Links Mothers’ Education Level to Telomere Length in Newborns
A small study of new mothers suggests that not having graduated from high school may impact the likelihood of babies being born with shortened telomeres.
Archive: Affordable Care Act Will Spur California Health Care Workforce to Develop New Leadership, Flexibility and People Skills
As health care shifts away from a fee-for-service model as a result of the ACA, health care workers in California will be called upon to develop new skills and fill new roles, according to a study led by UCSF researchers.
Archive: Mexico City Honors UCSF's Jaime Sepulveda for Pivotal Role in HIV/AIDS Prevention
To mark World AIDS Day, the government of Mexico City held a ribbon-cutting ceremony for a new HIV/AIDS clinic and named it for Jaime Sepulveda, MD, DSc, MPH, executive director of UCSF Global Health Sciences.
Archive: How an Approach Called ‘Shock and Kill’ Could Cure HIV
HIV can lurk for a lifetime in the body, so to truly cure patients, scientists are trying to find ways to target these HIV reservoirs in a strategy known as “shock and kill.”
Archive: SPARQ Project To Improve Care For Women In India, Kenya
UCSF's Global Health Sciences is launching a new project to improve care for women in India and Kenya, called the Strengthening People-centered Accessibility, Respect, and Quality (SPARQ) project, funded by the Bill and Melinda Gates Foundation and The David and Lucile Packard Foundation.
Archive: $20M Grant from amfAR Funds Institute for HIV Cure Research
In a bid to end the worst epidemic in modern times, the Foundation for AIDS Research (amfAR) is funding an ambitious effort based in San Francisco to eliminate the human immunodeficiency virus (HIV) from those who are infected.
Archive: Swaziland Likely To Be First To Eliminate Malaria In Southern Africa
The Malaria Elimination Group, an independent international advisory group on malaria elimination convened by the Global Health Group at the University of California, San Francisco (UCSF), gathered in the Ezulwini Valley for its tenth meeting to celebrate Swaziland’s achievements. The meeting was opened on November 16, 2015 by Swaziland’s Minister of Health, Honorable Sibongile Ndlela-Simelane.
Archive: Immunotherapy For Type 1 Diabetes Deemed Safe In First U.S. Trial
In the first U.S. safety trial of a new form of immunotherapy for type 1 diabetes, patients experienced no serious adverse reactions after receiving infusions of as many as 2.6 billion cells that had been specially selected to protect the body’s ability to produce insulin.